Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Intangibles (2016 - 2026)

Achieve Life Sciences' (ACHV) quarterly Intangibles came in at $696000.0 in Q1 2026, down 24.18% YoY from $918000.0 in Q1 2025, and down 7.32% on a QoQ basis from $751000.0 in Q4 2025.

Analysis

Achieve Life Sciences (ACHV) Intangibles (2016 - 2026) Analysis & Trends

Achieve Life Sciences (ACHV) has 11 years of Intangibles data on file, last reported at $696000.0 in Q1 2026.

  • Quarterly Intangibles fell 24.18% year-over-year to $696000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 24.18% YoY) and the FY2025 annual result came in at $751000.0, down 22.9% from the prior year.
  • Intangibles fell to $696000.0 in Q1 2026, from $751000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.6 million in Q1 2022 to a low of $696000.0 in Q1 2026.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Intangibles.
  • The widest YoY moves for Intangibles: up 12.33% in 2022, down 50.91% in 2022.
  • Tracing ACHV's Intangibles over 5 years: stood at $1.4 million in 2022, then decreased by 15.59% to $1.2 million in 2023, then fell by 18.63% to $974000.0 in 2024, then fell by 22.9% to $751000.0 in 2025, then dropped by 7.32% to $696000.0 in 2026.
  • The last three Intangibles figures came in at $696000.0 (Q1 2026), $751000.0 (Q4 2025), and $807000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 63.28 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 60.96 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 93.49 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn - 640,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 640,000.00
Mar 31, 2026 696,000.00
Dec 31, 2025 751,000.00
Sep 30, 2025 807,000.00
Jun 30, 2025 863,000.00
Mar 31, 2025 918,000.00
Dec 31, 2024 974,000.00
Sep 30, 2024 1.03 Mn
Jun 30, 2024 1.09 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.36 Mn
Dec 31, 2022 1.42 Mn
Sep 30, 2022 1.48 Mn
Jun 30, 2022 1.53 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 1.70 Mn